Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04431596 · ClinicalTrials.gov registry record · NA
Military Alerting System for Monitoring Body Temperature During Active Cooling
A NA study of Hyperthermia, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT04431596: Completed NA study of Hyperthermia, sponsored by University of Connecticut.
NCT04431596 is a NA study of Hyperthermia that has completed, run by University of Connecticut. The registered enrollment target is 12 participants, below the 49-participant average among 15 other Hyperthermia trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04431596, a NA study of Hyperthermia, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
BHSAI is developing a computational system that provides early alerts of a rise in core body temperature to help reduce the risk of heat injury in the field and during training. The goal of the body temperature alerting system is to use it during rest, exercise in the heat and during body cooling. Using this system during cooling will allow healthcare professionals and military personnel monitor core temperature to ensure cooling is effective (and prevent hypothermia). Therefore, the primary purpose of this investigation is to validate a body temperature alerting system using physiological responses that occur during rest, exercise in the heat and during body cooling. Multiple cooling modalities will be validated. The effectiveness of each cooling modality (passive cooling, mist-fan cooling, hand/forearm immersion) on physiological variables after exercise in the heat will be assessed. Lastly, subject characteristics (demographic and anthropometric characteristics) will be examined to examine their effect on physiological variables during exercise in the heat and during body cooling with each cooling modality.
Primary Outcome
Rectal thermometer will be self-inserted by participant to assess core temperature
Conditions Studied
Interventions
- DEVICE Forearm cooling
- OTHER Mist-fan cooling
Study Locations (1)
Connecticut
- Gampel Pavilion - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-09-04 |
| Est. Completion | 2020-12-09 |
| Phase | NA |
What the finished NCT04431596 record still lists
NCT04431596 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 49-participant average among 15 other Hyperthermia trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Hyperthermia appearing as the primary indexed condition, and to 2 interventions - of which Forearm cooling is the first listed.
NCT04431596 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04431596 about?
NCT04431596 is a clinical study titled "Military Alerting System for Monitoring Body Temperature During Active Cooling". BHSAI is developing a computational system that provides early alerts of a rise in core body temperature to help reduce the risk of heat injury in the field and during training. The goal of the body temperature alerting system is to use it during rest, exercise in the heat and during body cooling. U...
What is the current status of trial NCT04431596?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2020-09-04. Estimated completion is 2020-12-09.
What conditions does trial NCT04431596 study?
This clinical trial studies the following conditions: Hyperthermia.
What interventions are being tested in trial NCT04431596?
The interventions under investigation include: Forearm cooling (DEVICE), Mist-fan cooling (OTHER).
Who is sponsoring clinical trial NCT04431596?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04431596 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hyperthermia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04431596's enrollment target sits among peer trials
12 12th of 15 higher than 1 of 15 other Hyperthermia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hyperthermia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Predicting Responses to Exhausting, Prolonged, And Repeated Exercise Demands (PREPARED) for Heat
RECRUITING · NA
-
Heat Waves and the Elderly - Cooling Modalities
RECRUITING · NA
-
IEEM-Heat and Heart Failure
RECRUITING · NA
-
The Effectiveness of Emergency Room Protocols for Treating Hyperthermia
RECRUITING · NA
-
Skin Surface and Intradermal Temperature Responses to Heat Stress
ACTIVE NOT RECRUITING · NA
-
Renal Considerations in the Heat Stress Recommendations (Aim2)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI